A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis.

Baumhackl, U

A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis. [electronic resource] - Multiple sclerosis (Houndmills, Basingstoke, England) Apr 2005 - 166-8 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1352-4585

10.1191/1352458505ms1132oa doi


Administration, Oral
Adult
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Bromelains--administration & dosage
Double-Blind Method
Female
Humans
Magnetic Resonance Imaging
Male
Multiple Sclerosis, Relapsing-Remitting--drug therapy
Placebos
Recurrence
Rutin--administration & dosage
Treatment Outcome
Trypsin--administration & dosage